Joint Formulary & PAD

Botulinum toxin type A - Chronic sialorrhoea

You are here : Home > Formulary Search > Botulinum toxin type A - Chronic sialorrhoea

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important
ADULTS. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Botulinum toxin type A
Indication :
Chronic sialorrhoea
Group Name :
Keywords :
Brand Names Include :
Xeomin, Botox, Dysport
Important Information :
  • RSFT: Neurology Only
  • SASH: Xeomin only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

04 Dec 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Botulinum toxin type A is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Chronic sialorrhoea.

  • No records returned.